TobaccoReporter logo

Tag: pmi

  • PMI Talks Illicit Trade, Tobacco Reforms in Pakistan

    PMI Talks Illicit Trade, Tobacco Reforms in Pakistan

    Pakistan’s Federal Minister for Commerce Jam Kamal Khan met with a delegation from Philip Morris International to discuss challenges in the country’s tobacco sector, with a focus on illicit trade, regulatory gaps, and export potential. The delegation highlighted that an estimated 45–47 billion untaxed cigarettes are sold annually, contributing to revenue losses of around Rs350 billion ($1.3 billion) and creating competitive pressure on the formal sector. Discussions also addressed weaknesses in supply chain oversight, including tobacco leaf procurement and limited traceability, which enable informal manufacturing.

    Officials emphasized the need for stronger, coordinated enforcement across federal and provincial authorities, noting that existing regulations are often inconsistently applied. The role of the Pakistan Tobacco Board and broader policy challenges linked to IMF-related trade reforms were also reviewed, with both sides agreeing to continue collaboration on measures to improve compliance, strengthen monitoring systems, and support formal sector growth.

  • PMI’s Net Revenue Tops $40B for 2025

    PMI’s Net Revenue Tops $40B for 2025

    Philip Morris International highlighted strong financial performance and continued growth in its smoke-free portfolio during its 2026 Annual Meeting, reporting net revenues exceeding $40 billion in 2025, including nearly $17 billion from smoke-free products. The company said it delivered its fifth consecutive year of volume growth and remains focused on expanding its smoke-free business, which now accounts for a significant share of total revenues and is used by more than 43 million adult consumers globally.

    PMI reaffirmed its outlook for continued growth through 2026–2028 and its commitment to shareholder returns, while noting ongoing investments in innovation and regulatory progress for alternative products. The company also pointed to a complex operating environment, including regulatory pressures, geopolitical risks, and shifting consumer behavior, but said its performance in early 2026 supports confidence in achieving its long-term strategy.

  • Forbes Includes PMI Near Top of Net Zero Leaders List

    Forbes Includes PMI Near Top of Net Zero Leaders List

    Philip Morris International was named to Forbes’ 2026 Net Zero Leaders list, which recognizes U.S.-listed companies demonstrating measurable progress toward achieving net zero emissions. PMI ranked first in the fast-moving consumer goods category and fourth overall, based on assessments of governance, risk management, decarbonization performance, and financial resilience using data from Sustainalytics and Morningstar.

    The company reiterated its target to reach net zero greenhouse gas emissions across its value chain by 2040, ahead of the 2050 benchmark used by most companies. Recent milestones cited include the launch of its Value Plan 2030+, publication of an updated Climate Transition Plan, and continued progress toward science-based emissions reduction targets validated by the Science Based Targets initiative.

  • PMI Announces FDA Reauthorization of IQOS as MRTP

    PMI Announces FDA Reauthorization of IQOS as MRTP

    Today (April 29), Philip Morris announced that it has received renewed Modified Risk Tobacco Product (MRTP) authorizations from the U.S. Food and Drug Administration for its IQOS heated tobacco devices and associated HEETS consumables. The renewal covers two IQOS device versions and three HEETS variants, allowing the company to continue communicating reduced-exposure information to adult smokers in the U.S. The FDA said the decision is appropriate for the protection of public health, citing evidence that switching completely from cigarettes to IQOS significantly reduces exposure to harmful chemicals.

    The agency reaffirmed that available scientific evidence supports a measurable and substantial reduction in harm compared to combustible cigarettes, even without long-term epidemiological data. IQOS was first authorized through the FDA’s premarket pathway in 2019, with its initial MRTP designation granted in 2020 and expanded in subsequent years. The renewed orders maintain PMI’s position as the only company with MRTP authorizations for heated tobacco products in the U.S.

    The authorization applies to the IQOS 2.4 and IQOS 3 systems, along with HEETS Amber, Green Menthol and Blue Menthol variants. PMI said the decision supports its ongoing strategy to transition adult smokers away from cigarettes, as the company continues to invest in and expand its smoke-free product portfolio while awaiting further regulatory review of newer devices.

  • Philip Morris Korea Appoints New Managing Director

    Philip Morris Korea Appoints New Managing Director

    Philip Morris Korea named Lee Hong-suk as its new managing director, effective May 1, as the company continues to advance its smoke-free product strategy in the country. Lee, who has been with Philip Morris International since 1999, has held senior roles across multiple markets and most recently led the company’s smoke-free products division in Korea.

    In his new role, Lee will oversee operations in one of PMI’s key markets for alternatives such as IQOS, with a focus on expanding the company’s presence and engagement with stakeholders. The company said Lee will be essential as it continues to prioritize smoke-free product development and commercialization in the Korean market.

  • PMI Schedules 2026 Annual Shareholder Meeting

    PMI Schedules 2026 Annual Shareholder Meeting

    Philip Morris International announced that it will hold its 2026 Annual Meeting of Shareholders on May 6 at 9 a.m. ET via a live virtual webcast. The meeting will be accessible online, with presentation materials and a replay available for one year following the event.

    Chairman André Calantzopoulos and CEO Jacek Olczak are scheduled to address shareholders and respond to questions, with participation limited to verified shareholders using a control number.

  • Philippines Advocates Alleging Violations from Zyn, IQOS

    Philippines Advocates Alleging Violations from Zyn, IQOS

    Anti-smoking groups in the Philippines are calling on the Department of Trade and Industry (DTI) to act on complaints alleging violations of the Vape Regulation Act of 2022 by brands including Zyn and IQOS, according to the Sun Star. Advocacy organizations claim the products were promoted at public events such as the Sinulog Festival and through collaborations with artists, which they say are prohibited under the law that bans sponsorships and celebrity endorsements tied to nicotine products.

    Additional concerns were raised over product compliance, with some groups alleging that Zyn nicotine pouches are being sold without proper registration. The DTI, which has jurisdiction over vape-related regulation, is being urged to investigate and enforce existing rules, as advocates warn that continued non-compliance could increase youth exposure and undermine public health protections.

  • PM Plans Zyn Expansion in Tokyo

    PM Plans Zyn Expansion in Tokyo

    Philip Morris Japan announced it plans to expand sales of its oral nicotine pouch product “Zyn by IQOS” in Tokyo, with a broader rollout beginning May 11 across IQOS stores and convenience retailers. The product will be offered in Cool Mint, Spear Mint, Apple Mint, and Peach flavors, each with “low” and “medium” strength options. The company said the expansion reflects growing demand for discreet, smoke-free alternatives that can be used in a wider range of settings.

  • PMI Reduces Zyn Production in Owensboro

    PMI Reduces Zyn Production in Owensboro

    Philip Morris International announced it will scale back production at its Swedish Match facility in Owensboro, Kentucky, shifting part of its Zyn nicotine pouch operations from a 24/7 schedule to a 24/5 schedule beginning in early July, according to The Owensboro Times. The adjustment primarily affects the Zyn Flagship department, which will return to a five-day, three-shift model under the terms of the existing collective bargaining agreement.

    The company said the move reflects changing market conditions, with production currently exceeding demand following a period of rapid growth and capacity expansion. PMI invested more than $230 million into the Owensboro site in 2024, increasing output and adding approximately 450 jobs to support strong demand for Zyn products.

    PMI emphasized that the change is a production realignment rather than a reduction in long-term commitment to the facility, noting that other operations, including Zyn Ultra production and maintenance, will remain on a 24/7 schedule. The company said it will work with union leadership on staffing adjustments and indicated the schedule could return to continuous operations if demand increases.

  • PMI Expands Ducati Partnership to Promote Zyn

    PMI Expands Ducati Partnership to Promote Zyn

    Philip Morris International expanded its long-standing partnership with Ducati Corse, announcing that its Zyn nicotine pouch brand will be featured on MotoGP race liveries at select events starting in the 2026 season. The move marks a new phase in the collaboration, which dates back to 2003, and reflects PMI’s continued focus on promoting smoke-free products through high-profile global platforms.

    PMI said the partnership aligns with its broader strategy to grow its oral nicotine portfolio, with ZYN positioned as a key driver in the company’s transition away from cigarettes. Ducati said the renewed agreement builds on a shared emphasis on innovation and performance, as both organizations look to extend their presence and engagement with adult consumers in international markets.